4.8 Editorial Material

Adipose Modulation of High-Density Lipoprotein Cholesterol Implications for Obesity, High-Density Lipoprotein Metabolism, and Cardiovascular Disease

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

Amit V. Khera et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Adipocyte Modulation of High-Density Lipoprotein Cholesterol

YuZhen Zhang et al.

CIRCULATION (2010)

Editorial Material Cardiac & Cardiovascular Systems

Low High-Density Lipoprotein Cholesterol and Chronic Disease Risk

Jennifer G. Robinson

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Inflammation Impairs Reverse Cholesterol Transport In Vivo

Fiona C. McGillicuddy et al.

CIRCULATION (2009)

Article Medicine, General & Internal

Effects of torcetrapib in patients at high risk for coronary events

Philip J. Barter et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, Research & Experimental

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

JM Timmins et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Review Cardiac & Cardiovascular Systems

Regulation of reverse cholesterol transport and clinical implications

DJ Rader

AMERICAN JOURNAL OF CARDIOLOGY (2003)

Article Hematology

Importance of different pathways of cellular cholesterol efflux

PG Yancey et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)